标签：Pharmaceutical • 2023年5月12日 • 评论已关闭
China’s health insurance and National Reimbursement Drug List (NRDL) are significant for innovative drug products to reach the market in hospitals. Re…
标签：Pharmaceutical • 2023年3月23日 • 评论已关闭
The webinar aims to provide an overview of the regulatory landscape for generic drug registration in Singapore. It will allow listeners to be able to …
标签：Pharmaceutical • 2023年3月2日 • 评论已关闭
In last years, Latin America has become one of the regions which many pharmaceutical industries are focusing their projects, considering the populatio…
标签：Pharmaceutical • 2023年2月20日 • 评论已关闭
After consulting on the draft in Nov. 2022, China National Medical Products Administration (NMPA) released the Administrative Rules on Supervising Dru…
标签：Pharmaceutical • 2023年2月13日 • 评论已关闭
In 2022, China issued and implemented a series of drug regulations, including new rules for marketing authorization holders to manage drug quality and…
标签：Pharmaceutical • 2023年2月1日 • 评论已关闭
On May 13, 2021, China National Medical Products Administration (NMPA) released the Good Pharmacovigilance Practices (GVP), which has been effective s…
标签：Pharmaceutical • 2023年1月18日 • 评论已关闭
On Jan. 11, 2023, China Center for Drug Evaluation (CDE) released 10 Q&As, including nine questions on the electronic submission of drug applicati…
标签：Pharmaceutical • 2023年1月13日 • 评论已关闭
In July 2018, China optimized the clinical trial applications (CTA) / investigational new drug (IND) applications’ review and approval procedure…
标签：Pharmaceutical • 2022年12月16日 • 评论已关闭
In recent years, China has eased its market regulations when it comes to over-the-counter (OTC) medicines, allowing for the importation of OTC product…
标签：Pharmaceutical • 2022年12月14日 • 评论已关闭
This is a collection of China’s recent pharmaceutical laws, regulations, policies, and standards, mainly issued by the following authorities: National…
